MDPI and ACS Style
Cuevas-López, B.; Romero-Ramirez, E.I.; García-Arroyo, F.E.; Tapia, E.; León-Contreras, J.C.; Silva-Palacios, A.; Roldán, F.-J.; Campos, O.N.M.; Hernandez-Esquivel, L.; Marín-Hernández, A.;
et al. NAC Pre-Administration Prevents Cardiac Mitochondrial Bioenergetics, Dynamics, Biogenesis, and Redox Alteration in Folic Acid-AKI-Induced Cardio-Renal Syndrome Type 3. Antioxidants 2023, 12, 1592.
https://doi.org/10.3390/antiox12081592
AMA Style
Cuevas-López B, Romero-Ramirez EI, García-Arroyo FE, Tapia E, León-Contreras JC, Silva-Palacios A, Roldán F-J, Campos ONM, Hernandez-Esquivel L, Marín-Hernández A,
et al. NAC Pre-Administration Prevents Cardiac Mitochondrial Bioenergetics, Dynamics, Biogenesis, and Redox Alteration in Folic Acid-AKI-Induced Cardio-Renal Syndrome Type 3. Antioxidants. 2023; 12(8):1592.
https://doi.org/10.3390/antiox12081592
Chicago/Turabian Style
Cuevas-López, Belén, Edgar Ignacio Romero-Ramirez, Fernando E. García-Arroyo, Edilia Tapia, Juan Carlos León-Contreras, Alejandro Silva-Palacios, Francisco-Javier Roldán, Omar Noel Medina Campos, Luz Hernandez-Esquivel, Alvaro Marín-Hernández,
and et al. 2023. "NAC Pre-Administration Prevents Cardiac Mitochondrial Bioenergetics, Dynamics, Biogenesis, and Redox Alteration in Folic Acid-AKI-Induced Cardio-Renal Syndrome Type 3" Antioxidants 12, no. 8: 1592.
https://doi.org/10.3390/antiox12081592